癌症（英文版）2016，Vol.35Issue(6)：310-316,7.DOI:10.1186/s40880-016-0101-7
Hormonal therapy might be a better choice asmaintenance treatment thancapecitabine afterresponse toifrst-line capecitabine-based combination chemotherapy forpatients withhormone receptor-positive andHER2-negative, metastatic breast cancer
Hormonal therapy might be a better choice asmaintenance treatment thancapecitabine afterresponse toifrst-line capecitabine-based combination chemotherapy forpatients withhormone receptor-positive andHER2-negative, metastatic breast cancer
Xue-LianChen 1FengDu 1Ruo-XiHong 1Jia-YuWang 1YangLuo 1QingLi 1YingFan 1Bing-HeXu1
作者信息
- 1. Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Panjiayuan, Chaoyang District, Beijing 100021, P. R. China
- 折叠
摘要
关键词
Hormonal therapy/Maintenance capecitabine monotherapy/First-line capecitabine-based combination chemotherapy/Metastatic breast cancerKey words
Hormonal therapy/Maintenance capecitabine monotherapy/First-line capecitabine-based combination chemotherapy/Metastatic breast cancer引用本文复制引用
Xue-LianChen,FengDu,Ruo-XiHong,Jia-YuWang,YangLuo,QingLi,YingFan,Bing-HeXu..Hormonal therapy might be a better choice asmaintenance treatment thancapecitabine afterresponse toifrst-line capecitabine-based combination chemotherapy forpatients withhormone receptor-positive andHER2-negative, metastatic breast cancer[J].癌症（英文版）,2016,35(6):310-316,7.
